Rupert Major
Impact in
- Nephrology top 0.5%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Dialysis and Renal Disease Management
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Nephrology 29
- Chronic Kidney Disease and Diabetes 25
- Dialysis and Renal Disease Management 7
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Nigel John Brunskill (16 shared papers)Laura J. Gray (11 shared papers)Gang Xu (3 shared papers)David J. Shepherd (7 shared papers)Robert A. Grant (1 shared paper)Saran Shantikumar (1 shared paper)Simon Justin Girling (1 shared paper)Adrian A. Boyle (1 shared paper)
- Journals
- The Lancet (6 papers)Journal of the American Society of Nephrology (3 papers)Kidney International (3 papers)EClinicalMedicine (3 papers)European Journal of Preventive Cardiology (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Rupert Major
58 papers receiving 3.9k citations
Rupert Major's Hit Papers
Peers
Comparison fields: 5 of 141
- Nephrology 1.0k
- Infectious Diseases 1.0k
- Neurology 401
- Applied Microbiology and Biotechnology 50
- Internal Medicine 70
Countries citing papers authored by Rupert Major
This map shows the geographic impact of Rupert Major's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupert Major with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupert Major more than expected).
Fields of papers citing papers by Rupert Major
This network shows the impact of papers produced by Rupert Major. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupert Major. The network helps show where Rupert Major may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupert Major, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies Hit paper breakdown → | 2019 | 267 |
| 5 | Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis Hit paper breakdown → | 2020 | 248 |
| 6 | 2018 | 245 | |
| 7 | 2019 | 232 | |
| 8 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 230 |
| 9 | Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 211 |
| 10 | Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes Hit paper breakdown → | 2023 | 200 |
| 11 | 2018 | 191 | |
| 12 | 2020 | 112 | |
| 13 | 2019 | 103 | |
| 14 | 2020 | 90 | |
| 15 | 2023 | 83 | |
| 16 | 2018 | 67 | |
| 17 | 2010 | 65 | |
| 18 | 2019 | 62 | |
| 19 | 2022 | 54 | |
| 20 | 2015 | 53 |
About Rupert Major
Rupert Major is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Infectious Diseases, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 63 papers that have together received 4.1k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (25 papers), Dialysis and Renal Disease Management (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Blood Pressure and Hypertension Studies (3 papers), Renal and Vascular Pathologies (3 papers), COVID-19 Clinical Research Studies (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). The work is most often cited by research in Nephrology (1.0k citations), Infectious Diseases (1.0k citations), Neurology (401 citations), Applied Microbiology and Biotechnology (50 citations) and Internal Medicine (70 citations). Rupert Major has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Nigel John Brunskill, Laura J. Gray, Gang Xu, David J. Shepherd, Robert A. Grant, Saran Shantikumar, Simon Justin Girling, Adrian A. Boyle, James F. Medcalf and Gang Xu. Their work appears in journals such as The Lancet, Journal of the American Society of Nephrology, Kidney International, EClinicalMedicine and European Journal of Preventive Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.